Organon and Dermavant have entered a definitive agreement in which Organon will acquire Dermavant, according to a press release.
Organon is an independent global health care company dedicated to promoting women’s health.
“The acquisition will deliver on Organon’s objective of improving the health of women throughout their life stages by investing in treatments for conditions that affect women differently,” Kevin Ali, CEO of Organon, said in the release. “We look forward to combining Dermavant’s strong dermatology commercial and field medical organization in